|Page (1) of 1 - 04/13/18||email article||print page|
(April 13, 2018)
According to a new report published by Reports Monitor titled, “Insulin Market By Steel Product Type, Drug Type & Disease: Global Opportunity Analysis and Industry Forecast, 2017–2025,” the insulin market is projected to grow rapidly from 2017 to 2025. North American region dominates the insulin market, both in terms of volume and value, and is expected to maintain this trend throughout the forecast period.
Insulin regulates carbohydrates, fats and proteins metabolism in the body. The human insulin protein is composed of 51 amino acids. Insulin is a peptide hormone produced by beta cells of the pancreatic islets, and it is considered to be the main anabolic hormone of the body. It absorbs glucose from the blood and flows to liver, fat and skeletal muscle cells. The use of insulin is increasing due to the predominance of diabetes and obesity.
The major driver of insulin market is growing obesity and diabetes prevalence all over the world. Also extensive & well-established distribution network of insulin drugs in developed as well as fast developing countries boost the insulin market growth. Heavy investments in research and development of insulin products drive this market. The major challenges for insulin market will be, continuously growing competition among the manufacturers and suppliers, regulatory pressure, insurance coverage issues and high insulin cost.
Download PDF Brochure- https://goo.gl/F9LBQM
However, stringent regulatory requirements for product approval are restraining the growth of this market.
North American region is the global leader in insulin market in terms of values and extent due to high prevalence of diabetes and technological advances in effective insulin delivery. However, Asia-Pacific and LAMEA are the fastest growing geographic segments due to high diabetes incidences, government support and improving healthcare conditions.
Key Question Answered:
• What will be the market size in 2025 and at what rate it will grow?
• What trends, barriers, challenges are influencing its growth?
• Who are the major key players in global insulin market and what are their strategies?
• Which vertical industry is expected to show major growth?
• What segment and region will lead the market and why?
The major companies profiled in the report include: Novo Nordisk A/S, Eli Lilly and Company, Sanofi, Biocon, Tonghua Dongbao Pharmaceutical Co., Ltd., Adocia, Merck & Co., Inc., Pfizer, Inc., Wockhardt, Julphar, Bristol-Myers Squibb Company, GlaxoSmithKline Plc, Oramed Pharmaceuticals, Inc. and Other.
View Full Report Description with TOC- https://goo.gl/4Lfw2A
The report has been categorized in two distinctive sections, where the first category titled as Market Overview provides a holistic view of the market, key trends, drivers, challenges/restraints or opportunities with their current and expected impact on the overall industry sales.
Our analyst implement, several qualitative tools such as Ansoff’s Matrix, PESTEL analysis, Porter’s five force analysis among other to interpret and represent key industry findings.
The second section of the study provides market size, estimates and forecast for key market segments and regional market. The final part of the report highlights key manufacturers/vendors operating in the associated market.
Some Points from TOC-
1.1. Market Definition
1.2. Market Scope
2. Research Methodology
2.1. Primary Research
2.2. Secondary Sources
2.3. Assumptions & Exclusions
3. Market Overview
3.1. Research Report Segmentation & Scope
3.2. Key Market Trend Analysis
3.2.1. Market Drivers
3.2.2. Market Restraint/Challenges
3.2.3. Market Opportunities
3.3. Porter’s Five Forces Analysis
3.4. Potential Venture Avenues
3.5. Market Share Analysis, 2016
4. Product Type Overview
4.2. Market Size & Forecast, 2015 to 2025
4.2.1. Short-Acting Insulin
4.2.2. Intermediate-Acting Insulin
4.2.3. Long-Acting Insulin
4.2.4. Premixed Insulin
(Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)
View Full Press Release- http://garnerinsights.com/press-release/insulin-market
We at Garner Insights.com provide a comprehensive analysis by providing in-depth reports of the various market verticals. Our Mission is to provide a detailed analysis of the vast markets worldwide backed by rich data. Decision makers can now rely on our well-defined data gathering methods to get the correct and accurate market forecasting along with detailed analysis.
Company Name: Garner Insights
Contact Person: Kevin Thomas
Email: [email protected]
Phone: +1 513 549 5911
Related Keywords:Fitness,Health & Medicine,Pharmaceuticals & Biotech,Science,Technology,
Related Sites: DMN Newswire , HTN - Health Technology Net
Related Newsletter: Tutorial Finder , Review Seeker , DMN Newswire Newsletter